An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Reglan and Tardive Dyskinesia risk: what studies show — Research Summary
Detailed background, context, and analysis on this topic, compiled for open research purposes.
Reference: U.S. Food and Drug Administration (FDA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Wikipedia: Medical Malpractice
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Mayo Clinic — Diseases & Conditions
Authoritative source for clinical, regulatory, and public-health background reading.